Steroid-dependent Nephrotic Syndrome
📧 Sign up to get email alerts when something new happens for Steroid-dependent Nephrotic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome [Phase 3]
A Phase 3 clinical trial comparing repeated Rituximab courses to maintenance mycophenolate mofetil after an initial Rituximab course in chil…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome [Phase 2, Phase 3]
A phase 2/3 trial comparing obinutuzumab to rituximab in children with steroid-dependent or frequently relapsing nephrotic syndrome is curre…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Reduce Immunosuppression With Atmp in NS ChildrEn [Phase 2]
Phase 2 trial update investigating ATMP to reduce immunosuppression in children with steroid-dependent nephrotic syndrome.
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent nephrotic synd…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome [Phase 3]
A Phase 3 randomized trial comparing rituximab to mycophenolate mofetil in children with refractory nephrotic syndrome was terminated; resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: Rituximab Trial for Pediatric Nephrotic Syndrome [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating rituximab for pediatric nephrotic syndrome (steroid-resistant and steroid-dependent) with current status…